Lexaria Bioscience Corp. — Director's Dealing 2015

Dec 24, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-23	Common Shares	P	1500	$0.2	Acquired	6906814	Direct
2015-12-24	Common Shares	P	2000	$0.2	Acquired	6908814	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4937854	Indirect
Common Shares	6905314	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.1	2019-12-23	Common Shares (550000)	550000	Direct
Stock Options	$0.32	2016-07-11	Common Shares (220000)	770000	Direct
Stock Options	$0.09	2018-06-18	Common Shares (247500)	1017500	Direct
Warrants	$0.23	2017-05-15	Common Shares (187000)	187000	Indirect